Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

iNOS is a key mediator of anti-PD-1 melanoma therapy response.

Frontiers in immunology·2026
Same author

Strengthening Antisense Oligonucleotide-Mediated Anti-Tumor Immunity via Metal-Organic Framework Nanoparticles.

Nano letters·2026
Same author

The Myeloid Biomarker <i>MS4A6A</i> Drives an Immunosuppressive Microenvironment in Glioblastoma via Activation of the PGE2 Signaling Axis.

International journal of molecular sciences·2026
Same author

Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients.

Transplantation and cellular therapy·2025
Same author

Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma.

Frontiers in immunology·2025
Same author

Chemokine/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunity.

Proceedings of the National Academy of Sciences of the United States of America·2025

Related Experiment Video

Updated: Feb 26, 2026

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach
07:16

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Published on: April 25, 2025

842

Tumor-Associated Tertiary Lymphoid Structures: Gene-Expression Profiling and Their Bioengineering.

Genyuan Zhu1, Rana Falahat1, Kui Wang2,3

  • 1Immunology Department, Moffitt Cancer Center, Tampa, FL, United States.

Frontiers in Immunology
|July 18, 2017
PubMed
Summary

Tertiary lymphoid structures (TLSs) in tumors correlate with better survival in some cancers. Researchers identified a gene signature for TLSs and are developing engineered TLSs to improve cancer immunotherapy.

Keywords:
antitumorbioengineeringchemokinesimmune cellsscaffolds

More Related Videos

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.6K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.5K

Related Experiment Videos

Last Updated: Feb 26, 2026

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach
07:16

Three-Dimensional Imaging of Tumor-Bearing Tissue Using the Iterative Bleaching Extends Multiplexity Approach

Published on: April 25, 2025

842
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.6K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

10.5K

Area of Science:

  • Immunology
  • Oncology
  • Bioengineering

Background:

  • Tertiary lymphoid structures (TLSs) are found in human solid tumors.
  • TLS presence correlates with improved patient outcomes in certain cancers.
  • The functional role of tumor-localized TLSs is under intensive investigation.

Purpose of the Study:

  • To understand the influence of TLSs on the tumor microenvironment.
  • To leverage TLSs for manipulating antitumor immune responses.
  • To enhance cancer immunotherapy applications by engineering TLSs.

Main Methods:

  • Identification of a 12-chemokine gene-expression signature for detecting TLSs in tumors.
  • Analysis of TLS presence and correlation with patient outcomes.
  • Bioengineering approaches for designing and constructing artificial TLSs.

Main Results:

  • A specific tumor-derived immune gene signature reliably identifies TLS presence in various solid tumors.
  • TLSs are associated with better patient survival in specific cancer types.
  • Not all solid tumors naturally contain TLSs.

Conclusions:

  • TLSs play a significant role in the tumor microenvironment and patient prognosis.
  • Targeting TLSs offers potential for enhancing cancer immunotherapy.
  • Engineered TLSs may address unmet needs in patients lacking natural lymphoid structures in their tumors.